VIDEO: Professor Fred Saad on ARANOTE findings, implications of PSA response and choosing the most appropriate treatment option for mHSPC patients
12 Aug 2025
byProf. Fred Saad, Professor and Chief of Urology, Director of GU Oncology, University of Montreal, Canada
Prof Fred Saad, Director of GU Oncology at the University of Montreal, Canada, and principal investigator of the ARANOTE trial, discusses ARANOTE findings, implications of PSA response and choosing the most appropriate treatment option for mHSPC patients.
